as 99 tfa

AS-99 TFA is a potent, and selective ASH1L histone methyltransferase inhibitor with an IC50 of 0.79 μM. It exhibits robust anti-leukemic activity by blocking cell proliferation, inducing apoptosis and differentiation. AS-99 TFA exerts its effects by downregulating MLL fusion target genes and has been shown to significantly reduce leukemia burden in vivo.

OM99-2 TFA is an eight-residue peptidomimetic compound, functioning as a tight-binding inhibitor of human brain memapsin 2. It exhibits a high affinity for the target with a Ki value of 9.58 nM, making it a promising candidate in the development of BACE1 inhibitors. Due to its potential, OM99-2 presents opportunities for further research in the field of Alzheimer's disease.

Myelin Basic Protein (87-99) TFA, an encephalitogenic peptide, promotes basic protein-specific T cell proliferation and induces Th1 polarization in peripheral blood mononuclear cells, contributing to the pathogenesis of multiple sclerosis (MS) [1] [2].